USPTO Art Unit 1655 Prosecution Statistics

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19417541ACACIA NILOTICA BASED HYDROGEL AND METHOD OF MAKING THE SAMEDecember 2025February 2026Allow200NoNo
19324396MARINE ORGANISM DERIVED SURFACTANTSeptember 2025February 2026Allow501NoNo
19280968COMBINATION OF NON-VIABLE CELLS OF STREPTOCOCCUS PYOGENES AND IMMUNE CHECKPOINT INHIBITOR FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER AND NON-MUSCLE INVASIVE BLADDER CANCERJuly 2025October 2025Allow300NoNo
19277384HERBAL ORAL COMPOSITIONS HAVING THE PROPERTIES FOR SUPPORTING AND ENHANCING MUSCULOSKELETAL HEALTH AND METHOD OF MANUFACTURING THE SAMEJuly 2025November 2025Allow410NoNo
19275921PLANT-BASED EXTRACT COMPLEX COMPOSITION HAVING THE PROPERTIES FOR SUPPORTING THE RELIEF OF MUSCULOSKELETAL PAIN, ANTIBACTERIAL AND ANTI-INFLAMMATORY AND PROCESS OF MANUFACTURING THE SAMEJuly 2025November 2025Allow411NoNo
19269552CELLS, TISSUES, ORGANS, AND ANIMALS HAVING ONE OR MORE MODIFIED GENES FOR ENHANCED XENOGRAFT SURVIVAL AND TOLERANCEJuly 2025November 2025Allow401NoNo
19252680LIQUID DISPENSING SYSTEM, COMPONENTS AND FEATURES THEREOF, AND METHODS OF USE THEREOFJune 2025March 2026Allow811NoNo
19247982APPARATUS FOR TISSUE TRANSPORT AND PRESERVATIONJune 2025March 2026Allow811NoNo
19242278CLINICAL DRESSING LOADED WITH COFFEE EXTRACTJune 2025January 2026Allow710NoNo
19241614CLINICAL DRESSING LOADED WITH COFFEE EXTRACTJune 2025February 2026Allow810NoNo
19206261PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSIONMay 2025February 2026Allow912NoNo
19205571METHODS TO PRODUCE PRODUCTS COMPRISING CANNABINOIDSMay 2025August 2025Allow300NoNo
19205709Vaporized Medicants and Methods of UseMay 2025January 2026Abandon810NoNo
19205994SYSTEM FOR INDUCING MUTATION BASED ON OPTIMIZED ACTIVATION-INDUCED CYTIDINE DEAMINASEMay 2025December 2025Allow710NoNo
19190359ANTIMICROBIAL COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAMEApril 2025November 2025Allow710YesNo
19187591STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONSApril 2025January 2026Allow911NoNo
19187241STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONSApril 2025January 2026Allow920NoNo
19183815COMPOSITIONS AND METHODS OF ACHIEVING PAIN RELIEFApril 2025June 2025Allow101YesNo
19183742ALBUMIN RICH PEA PROTEIN ISOLATE AND PROCESS FOR PRODUCTION THEREOFApril 2025September 2025Allow501NoNo
19091737METHODS AND CHEMICAL COMPOSITIONS FOR TREATING SKIN CONDITIONS BY PROVIDING LONG LASTING SKIN PH CONTROL FOR IMPROVING SKIN BARRIER FUNCTIONMarch 2025July 2025Allow410YesNo
19064774COMPOSITION AND METHOD FOR INDUCING NATURAL CONCEPTIONFebruary 2025August 2025Allow610YesNo
19066076METHOD FOR PRODUCING A PLANT-BASED EXTRACT COMPOSITION HAVING THE EFFECT OF ENHANCING NUTRITION AND IMMUNITYFebruary 2025June 2025Allow411YesNo
19027003DIOXYGENASE MUTANTS AND USE THEREOF IN SYNTHESIZING (2S,3R)-3-HYDROXYPIPECOLIC ACIDJanuary 2025August 2025Allow711YesNo
19012840POLYSACCHARIDE COMPOUND WITH A DEFINED MOLECULAR STRUCTURE THAT CAN ELIMINATE THE TOXIC SIDE EFFECTS OF CHEMOTHERAPY DRUGSJanuary 2025June 2025Allow501YesNo
19005323PREPARATION METHOD FOR BIOSYNTHESIS OF HUMAN BODY STRUCTURAL MATERIALDecember 2024December 2025Allow1211YesNo
18980483TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING CORONARY MYOCARDIAL BRIDGE AND APPLICATION THEREOFDecember 2024July 2025Allow711YesNo
18972246TRADITIONAL CHINESE HERBAL COMPOSITION FOR TREATMENT OF BACTERIAL VAGINOSIS AND PREPARATION METHOD THEREOFDecember 2024February 2025Allow200NoNo
18961323RHODOSORUS MARINUS AND APPLICATION THEREOF IN PREPARING FACIAL MASKSNovember 2024June 2025Allow711NoNo
18947697CHINESE HERBAL MEDICINE COMPOSITION FOR BOOSTING IMMUNITY, AND PREPARATION METHOD AND USE THEREOFNovember 2024June 2025Allow711NoNo
18948016PEONY STAMEN-DODDER COMPOSITE, AND ITS PREPARATION METHOD AND APPLICATIONNovember 2024January 2025Allow200YesNo
18942174PRODUCTION OF PROTEINS IN GLUTAMINE-FREE CELL CULTURE MEDIANovember 2024May 2025Allow610NoNo
18934450ESSENTIAL OIL OF STEMS AND LEAVES OF CHUZHOU CHRYSANTHEMUM AND APPLICATION THEREOFNovember 2024March 2025Allow401NoNo
18926515GAME ATTRACTANT AND VARMINT REPELLENT COMPOSITIONS AND METHODSOctober 2024March 2025Allow511YesNo
18917986COMPOSITIONS AND METHODS FOR ACCELERATING DEVELOPMENT OF CANCER THERAPEUTICSOctober 2024November 2025Abandon1310NoNo
18911447MEDICINAL MUSHROOM-BASED TOPICAL COMPOSITIONOctober 2024January 2025Allow411YesNo
18907606ANTIBACTERIAL MODIFIED CHITOSAN-BASED HEMOSTATIC MATERIAL AND METHOD OF MANUFACTURING THE SAMEOctober 2024January 2025Allow301NoNo
18906311MEDICAL TREATMENT COMPOSITION, METHOD OF PREPARATION AND TREATMENT METHODOctober 2024May 2025Allow710YesNo
18902831METHOD FOR TREATING AND PREVENTING ULCERATIVE COLITIS AND METHOD FOR DAI REDUCTIONSeptember 2024December 2025Allow1421YesNo
18894385COMPOSITION FOR WEIGHT REDUCTION AND BODY FAT REDUCTION, PREPARATION METHOD AND APPLICATION THEREOFSeptember 2024April 2025Allow611NoNo
18844892METHOD FOR IMPROVING HEALTH CONDITION OF MAMMAL OR FARM ANIMALSeptember 2024February 2025Allow500NoNo
18826102MODIFICATION OF NATURAL COMPOUNDS TO CREATE PRODUCTS WITH ENHANCED HEALTH BENEFITSSeptember 2024June 2025Allow911YesNo
18843852USE OF MULBERRY TWIG ALKALOIDS IN PREPARATION OF DRUG FOR TREATING POLYCYSTIC OVARIAN SYNDROMESeptember 2024September 2025Allow1311NoNo
18818636CHITOSAN COMPOSITION AND METHOD OF MANUFACTURING THE SAMEAugust 2024November 2024Allow200NoNo
18813643ENGINEERED MCP PROTEINS AND SYSTEMS THEREOFAugust 2024January 2026Allow1721NoNo
18806538METHODS OF INHIBITING CANCER GROWTH AND INHIBITING VIRAL INFECTIONSAugust 2024April 2025Allow811YesNo
18806195SKIN CARE FORMULATIONSAugust 2024October 2025Allow1400NoNo
18796479Curcuminoid composition of Curcumin-keto, method of preparation and use thereofAugust 2024November 2024Allow310YesNo
18794793ANTIMICROBIAL COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAMEAugust 2024January 2025Allow501YesNo
18773936OKRA-DERIVED ANTIVIRAL COMPOSITION AND USES THEREOFJuly 2024May 2025Allow1001NoNo
18764014FORMULATIONS AND METHODS FOR SKIN CAREJuly 2024December 2024Allow511YesNo
18762301COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSIONJuly 2024October 2025Allow1521NoYes
18760356COSMETIC COMPOSITIONJuly 2024February 2026Allow2010YesNo
18759705EYE HEALTH SUPPLEMENT WITH CURCUMINJune 2024September 2025Allow1411NoNo
18757390STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONSJune 2024December 2024Allow510NoNo
18750691STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONSJune 2024March 2025Allow921NoNo
18746153MUNG BEAN HULL EXTRACT WITH ANTIVIRAL EFFECT AND EXTRACTION METHOD THEREOFJune 2024April 2025Allow1001NoNo
18745674COMPOSITIONS AND METHOD FOR TREATING AND PREVENTING COMPLICATIONS OF OBESITYJune 2024April 2025Allow1011NoNo
18744608PROCESS FOR CREATING A CANNABINOID PICO-EMULSION WITH ANTIBIOTIC PROPERTIES AND THE RESULTING PICO-EMULSIONJune 2024February 2026Allow2001NoNo
18736592TRADITIONAL CHINESE MEDICINE COMPOUND FOR PREVENTING AND TREATING AFRICAN SWINE FEVER, AND ITS EFFICIENCY ENHANCEMENT PROCESS AND APPLICATIONJune 2024October 2024Allow501NoNo
18736009PEST CONTROL USING NATURAL PEST CONTROL AGENT BLENDSJune 2024January 2025Allow821YesNo
18733907URINARY SYSTEM CATHETER USING ETHANOL EXTRACT OF PROPOLIS AS COATING AND PREPARATION METHOD THEREOFJune 2024February 2025Allow810NoNo
18734602PHARMACEUTICAL COMPOSITION AND COSMETIC COMPOSITIONJune 2024April 2025Allow1001YesNo
18734385PHOSPHOLIPID COMPOSITIONS FOR DELIVERY OF THERAPEUTIC COMPOUNDSJune 2024December 2025Allow1810NoNo
18731591BIOCONTROL FORMULATION FOR CONTROLLING PLANT PATHOGENSJune 2024July 2025Allow1421NoNo
18715154TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOFMay 2024July 2025Allow1420NoNo
18679420CLINICAL DRESSING LOADED WITH COFFEE EXTRACTMay 2024June 2025Allow1211NoNo
18674967COMPOSITIONS COMPRISING AN AMERICAN CRANBERRY EXTRACT AND PHOSPHOLIPIDSMay 2024March 2026Allow2130YesNo
18669326HEALTH BENEFITING COMPOSITIONS OF DAILY NUTRITION AND METHODS OF USE THEREOFMay 2024January 2026Allow2011NoNo
18669211Composition for Relieving Sleep Disorder and its Application Method ThereofMay 2024December 2024Allow700YesNo
18667139HERBAL COMPOSITION PHY906 AND ITS USE IN CHEMOTHERAPYMay 2024January 2025Allow800YesNo
18665693Chemical Processes And Apparatuses For Extracting Organic Compounds From Biomass With Volatile Organic Compound RemovalMay 2024August 2024Allow301NoNo
18665356LACTIPLANTIBACILLUS PLANTARUM EL6 FOR INCREASING FLAVONOID CONTENT, AND USE THEREOFMay 2024January 2026Abandon2021NoNo
18709625SKIN CARE COMPOSITIONMay 2024March 2026Allow2200YesNo
18661900COMPOSITION FOR TREATING BONE LOSSMay 2024July 2024Allow200NoNo
18659048OKRA EXTRACT AS A SUBSTITUTE FOR CERVICAL MUCUSMay 2024August 2025Allow1500NoNo
18659701COMPOSITIONS OF HERBAL FORMULATIONS AND USES THEREOFMay 2024May 2025Allow1301YesNo
18658120USE OF RAMIE EXTRACT IN PREPARING A COMPOSITION FOR IMPROVING THE ACTIVITY OF MITOCHONDRIA AND IMPROVING THE ACTIVITY OF TELOMERASEMay 2024September 2025Allow1700NoNo
18655974STABILIZED COMPOSITIONS COMPRISING CANNABIDIOLMay 2024January 2025Allow901YesNo
18654377BARRIER GUARD TECHNOLOGYMay 2024December 2024Allow800YesNo
18651875HERBAL PRODUCTS AND METHODS FOR TETRAHYDROCANNABINOL (THC) DETOXIFICATIONMay 2024February 2025Allow901NoNo
18652734GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USINGMay 2024March 2026Allow2221NoNo
18650432CANNABIDIOL AND ACTIVE DELIVERY SYSTEMSApril 2024March 2025Allow1000NoNo
18648175COMPOSITIONS AND METHODS FOR ALLEVIATING ADVERSE EFFECTS FROM RESPONSIBLE ALCOHOL CONSUMPTIONApril 2024February 2025Allow1021YesNo
18645314METHODS OF TREATING BLEEDING IN A SUBJECT TREATED WITH AN ANTIPLATELET AGENTApril 2024September 2024Allow510NoNo
18643408METHOD FOR INHIBITING ENZYME ACTIVITY USING BOSCIA SENEGALENSISApril 2024September 2024Allow510NoNo
18641861COMPOSITIONS AND METHODS FOR TREATING AND MANAGING CHRONIC INFLAMMATORY SKIN DISORDERSApril 2024July 2025Allow1421YesYes
18641028COMPOSITION FOR RESPIRATORY DISEASESApril 2024January 2026Allow2121YesNo
18639285METHODS OF TREATING ENDOMETRIOSIS AND OTHER NONCANCER GYNECOLOGICAL DISORDERS WITH HEMP EXTRACTApril 2024May 2025Allow1311YesNo
18635597METHODS OF TREATING OVARIAN CANCER WITH HEMP EXTRACTApril 2024June 2025Allow1410NoNo
18632657FLAMMULINA VELUTIPES PROTEOGLYCAN (FPG) AND DUAL-WAVELENGTH SCREENING METHOD AND USE THEREOFApril 2024August 2025Abandon1621NoNo
18630703COMPOSITION FOR IMPROVING SKIN MOISTURIZATION OF COMPANION ANIMALSApril 2024July 2024Allow410NoNo
18626055GENETICALLY MODIFIED ZYMOMONAS MOBILIS TO UTILIZE INORGANIC N SOURCE, METHODS AND USES THEREOFApril 2024September 2024Allow501NoNo
18621062TRADITIONAL CHINESE MEDICINE COMPOUND FOR IMPROVING TESTICULAR DYSFUNCTION, PREPARATION METHOD AND APPLICATION THEREOFMarch 2024October 2024Allow711YesNo
18615843HEMP COMPOSITIONS AND METHODS OF MAKING THE SAMEMarch 2024September 2025Abandon1801NoNo
18613594WEIGHT LOSS SUPPLEMENT COMPOSITION AND METHOD OF PREPARING THE SAMEMarch 2024October 2025Allow1971YesNo
18605547NANOBANDAGE SOLUTION WITH FAIDHERBIA ALBIDA NANOPARTICLES AND NATURAL AND SYNTHETIC POLYMERSMarch 2024November 2024Allow811NoNo
18603498ESSENTIAL OIL COMPOSITION AND PREPARATION METHOD THEREOFMarch 2024October 2024Allow711NoNo
18597236COMPOSITIONS COMPRISING CANNABIS AND MUSHROOM EXTRACTS, AND USES THEREOFMarch 2024December 2024Allow900NoNo
18594014PROCESS OF MANUFACTURING COMPOSITION FOR THE PREVENTION AND TREATMENT OF EARLY MORTALITY SYNDROME (EMS) SHRIMPMarch 2024July 2024Allow411NoNo
18592551METHOD FOR PRODUCING A COMPLEX COMPOSITION OF TURKEY TAIL MUSHROOM EXTRACT- CHITOSANMarch 2024June 2024Allow311NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for art-unit 1655.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
184
Examiner Affirmed
141
(76.6%)
Examiner Reversed
43
(23.4%)
Reversal Percentile
11.1%
Lower than average

What This Means

With a 23.4% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
1152
Allowed After Appeal Filing
297
(25.8%)
Not Allowed After Appeal Filing
855
(74.2%)
Filing Benefit Percentile
18.2%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 25.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Art Unit 1655 - Prosecution Statistics Summary

Executive Summary

Art Unit 1655 is part of Group 1650 in Technology Center 1600. This art unit has examined 14,240 patent applications in our dataset, with an overall allowance rate of 54.7%. Applications typically reach final disposition in approximately 32 months.

Comparative Analysis

Art Unit 1655's allowance rate of 54.7% places it in the 11% percentile among all USPTO art units. This art unit has a significantly lower allowance rate than most art units at the USPTO.

Prosecution Patterns

Applications in Art Unit 1655 receive an average of 1.78 office actions before reaching final disposition (in the 40% percentile). The median prosecution time is 32 months (in the 40% percentile).

Strategic Considerations

When prosecuting applications in this art unit, consider the following:

  • The art unit's allowance rate suggests a more challenging examination environment compared to the USPTO average.
  • With fewer office actions than average, plan for relatively streamlined prosecution.
  • The median prosecution time is longer than average and should be factored into your continuation and client communication strategies.
  • Review individual examiner statistics within this art unit to identify examiners with particularly favorable or challenging prosecution patterns.

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.